Buscar
Congreso SOLACI
HomeInternational CongressesESC 2012

ESC 2012

Ver Categoría
Day 3

PRAGUE-12: Surgical Atrial Ablation: Follow the one-year results.

Review: Two hundred twenty-four patients in a surgical plan, (coronary artery bypass grafting or valve), were randomized...
solaci -
Ver más
Day 3

AFIB ABLATION PILOT: Ablation of Atrial Fibrillation by Radiofrequency.

Review: A European multicenter registry, (mainly in France, Italy and Germany), which included 1,410 patients - evidence...
solaci -
Ver más
Day 3

CORE 320: Diagnostic performance of coronary angiotomography including evaluation of myocardial perfusion versus isolated anatomical assessment.

Review: The CORE-320 multicenter study compared combined angiotomography assessments: anatomical (coronary) and functional (myocardial perfusion) versus anatomical...
solaci -
Ver más
Day 3

JAPAN EQ: Cardiovascular risk after natural disasters.

Natural disasters have been associated with an increase in cardiovascular mortality. In the Miyagi area, near the...
solaci -
Ver más
Day 3

WOEST: Randomized trial that compared dual therapy versus triple therapy on anticoagulated patients.

A multicenter randomized study, (n = 573), that evaluated the role of aspirin in anticoagulated patients undergoing...
solaci -
Ver más
Day 1

TRILOGY-ACS: Prasugrel vs. Clopidogrel in ACS without ST segment elevation in patients to be treated medically without revascularization.

 TRILOGY-ACS: Prasugrel vs. Clopidogrel in ACS without ST segment elevation in patients to be treated medically without...
solaci -
Ver más
Day 3

FAME II: Ischemia guided (IG) percutaneous coronary intervention (PCI) is superior to medical treatment.

Review: Stable coronary disease remains a scenario where percutaneous coronary intervention, (PCI), has not cleared the edges....
solaci -
Ver más
Day 2

ACCESS-EUROPE: 12 months results in percutaneous treatment of mitral insufficiency .

Presentation Summary: ACCESS-EUROPE multicenter registry included 567 patients with severe mitral regurgitation treated with Mitral Clip in...
solaci -
Ver más

SOLACI es la organización de referencia del intervencionismo cardiovascular latinoamericano.

Últimas Noticias

Severe Tricuspid Regurgitation: Surgical vs. Transcatheter Edge-to-Edge Repair

Dr. Omar Tupayachi - 0
While highly prevalent, tricuspid regurgitation is a notably undertreated valvulopathy. Its progression has been associated with higher mortality and significant disability. According to the...

ACCESS-TAVI: Comparing Post TAVR Vascular Closure Devices

Dr. Andrés Rodríguez - 0
Transcatheter aortic valve replacement (TAVR) is a well-established option to treat elderly patients with severe symptomatic aortic valve stenosis. Technical advances and device development...

Endovascular Treatment of Iliofemoral Disease for the Improvement of Heart Failure with Preserved Ejection Fraction

Dr. Omar Tupayachi - 0
Peripheral artery disease (PAD) is a significant risk factor in the development of difficult-to-treat conditions, such as heart failure with preserved ejection fraction (HFpEF)....

Noticias Institucionales

Check out the best images of the El Salvador 2024 Sessions

solaci - 0
Review the highlights of the XLIX SOLACI Regional Sessions held at the Intercontinental Hotel in San Salvador, El Salvador between November 7 and 8,...

The El Salvador 2024 Sessions are coming soon

solaci - 0
The XLIX SOLACI 2024 Regional Sessions (17th Central America & the Caribbean) are approaching, and will take place in the city of San Salvador (El Salvador)....

Check out the best images of the Arequipa 2024 Sessions

solaci - 0
Review the highlights of the XVIII SOLACI Regional Sessions held at the Hanan Hotel in Arequipa, Peru between October 3 and 4, 2024. <!-- wp:tw/bwg...

Accesos

Adolfo Alsina 2653 · Piso 2H · CABA · Buenos Aires · Argentina · (5411) 4954 7173 · info@solaci.org · solaci.org · Términos de uso -Políticas de privacidad